Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;103(3):426-34.
doi: 10.2105/AJPH.2012.300693. Epub 2012 Jun 14.

Rethinking antibiotic research and development: World War II and the penicillin collaborative

Affiliations

Rethinking antibiotic research and development: World War II and the penicillin collaborative

Roswell Quinn. Am J Public Health. 2013 Mar.

Abstract

Policy leaders and public health experts may be overlooking effective ways to stimulate innovative antibiotic research and development. I analyzed archival resources concerning the US government's efforts to produce penicillin during World War II, which demonstrate how much science policy can differ from present approaches. By contrast to current attempts to invigorate commercial participation in antibiotic development, the effort to develop the first commercially produced antibiotic did not rely on economic enticements or the further privatization of scientific resources. Rather, this extremely successful scientific and, ultimately, commercial endeavor was rooted in government stewardship, intraindustry cooperation, and the open exchange of scientific information. For policymakers facing the problem of stimulating antibiotic research and development, the origins of the antibiotic era offer a template for effective policy solutions that concentrate primarily on scientific rather than commercial goals.

PubMed Disclaimer

Figures

None
This poster appeared on the walls of fermentation plants producing penicillin during World War II. Source. Record Group 44, Records of the Office of Government Reports, 1932–1947, 44-PA-1505 “Penicillin Saves Soldiers' Lives! Every Minute Saved in Building This Plant Means a Life Saved on the Fighting Fronts. Give This Job Everything You’ve Got, 1941–1954,” National Archives, College Park, MD.
None
Andrew Moyer, the Northern Regional Research Laboratory scientist who perfected the initial growth medium used for penicillin production during the war effort, points to the mycelium, or matt of mold growth, floating about the growth medium into which it secretes penicillin. Source. Record Group 208, Records of the Office of War Information, 1926–1951, Still Pictures and Records Section, 208-SAI-1-55 Antibiotics, National Archives, College Park, MD.
None
This diagram depicts how government scientists, lacking commercial barriers, coordinated the selection, trafficking, and alteration of penicillin mold strains between multiple groups. Source. William D. Gray, The Relations of Fungi to Human Affairs (New York: Henry Holt, 1959), 153. Note. NRRL = Northern Regional Research Laboratory; UV = ultraviolet.
None
Huge containers of mold and growth medium with submerged fermenters revolutionized penicillin production and enabled the pharmaceutical industry to produce large, refined quantities of complex biological materials. Source. Record Group 208, Records of the Office of War Information, 1926—1951, Still Pictures and Records Section, 208-SAI-1-18 Antibiotics, National Archives, College Park, Md.

References

    1. Spellberg Brad, PowersJohn H, Pc BrassEric, Loren MillerG, and EdwardsJohn E Jr. “Trends in Antimicrobial Drug Development: Implications for the Future, ” Clinical Infectious Diseases 38, no. 9(2004): 1279–86. - PubMed
    1. ProjanSteven J, “Why is Big Pharma Getting Out of Antibacterial Drug Discovery?” Current Opinion in Microbiology 6, no. 5(2003): 428. - PubMed
    1. SellersL J, “Big Pharma Bails on Anti-infectives Research, ” Pharmaceutical Executive 23, no. 12(2003): 22.
    1. ShlaesDavid M, “The Abandonment of Antibacterials: Why and Wherefore?” Current Opinion in Pharmacology 3, no. 5(2003): 470–3; Projan, “Why is Pharma Getting Out?” 428; Infectious Diseases Society of America, Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates… A Public Health Crisis Brews (Alexandria, Va: ISDA, 2004)
    1. Spellberg et al., “Trends in Antimicrobial Drug Development, ” 1281.

Publication types

LinkOut - more resources